Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Blumenthal

Showing results (841-850 of 843) with videos related to

Pageof 85
Sort By:
You have reached the last page of results.This site can display upto 843 results.
Journal of the American College of Cardiology|March 13, 2026
2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice GuidelinesRoger S Blumenthal, Pamela B Morris, Mario Gaudino, et al.
Nephron|June 20, 2015
A Multicenter Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (MENTOR)Fernando C Fervenza, Pietro A Canetta, Sean J Barbour, et al.
The New England Journal of Medicine|July 4, 2019
Rituximab or Cyclosporine in the Treatment of Membranous NephropathyFernando C Fervenza, Gerald B Appel, Sean J Barbour, et al.
Pageof 85

Showing results (841-850 of 843) with videos related to

Sort By:
Pageof 85
You have reached the last page of results.This site can display upto 843 results.
Journal of the American College of Cardiology|March 13, 2026
2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice GuidelinesRoger S Blumenthal, Pamela B Morris, Mario Gaudino, et al.
Nephron|June 20, 2015
A Multicenter Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (MENTOR)Fernando C Fervenza, Pietro A Canetta, Sean J Barbour, et al.
The New England Journal of Medicine|July 4, 2019
Rituximab or Cyclosporine in the Treatment of Membranous NephropathyFernando C Fervenza, Gerald B Appel, Sean J Barbour, et al.
Pageof 85